Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early Detection of Thromboembolism during Open Repair for Complex Aortoiliac Aneurysms Using Continuous Noninvasive Lower Limb Oximetry.

Annals of vascular diseases·2026
Same author

Left Ventricular Venting Using a Transaortic Pigtail Catheter in Pediatric Myocarditis Requiring Extracorporeal Membrane Oxygenation.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2026
Same author

Staged repair of the anomalous origin of the right pulmonary artery from the ascending aorta with aortic coarctation.

Annals of pediatric cardiology·2026
Same author

Hepatic vein-derived factors may affect pulmonary arteriovenous malformations after single ventricle palliation by modulating vascular cell behavior.

Scientific reports·2025
Same author

An iPSC-based in vitro model recapitulates human thymic epithelial development and multi-lineage specification.

Nature communications·2025
Same author

[Maze Surgery Using the General-purpose Cryosurgical Unit 'Freeze Stick M'].

Kyobu geka. The Japanese journal of thoracic surgery·2025

Related Experiment Video

Updated: May 5, 2026

The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy
07:51

The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy

Published on: June 1, 2019

21.3K

Re-sentinel node biopsy after previous breast and axillary surgery.

Tadashi Ikeda1

  • 1Department of Surgery, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi-ku, Tokyo, 160-8582, Japan, ikedat@med.teikyo-u.ac.jp.

Surgery Today
|November 21, 2013
PubMed
Summary

Re-sentinel lymph node biopsy (re-SLNB) is a feasible option for managing breast cancer recurrence, with accuracy comparable to initial biopsies. Further research is needed to establish clear recommendations due to varied identification rates and short follow-up periods.

More Related Videos

Single-port Non-liposuction Endoscopic Axillary Lymph Node Dissection in Breast Cancer Surgery
11:49

Single-port Non-liposuction Endoscopic Axillary Lymph Node Dissection in Breast Cancer Surgery

Published on: April 3, 2026

481
Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
03:07

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial

Published on: August 19, 2025

1.6K

Related Experiment Videos

Last Updated: May 5, 2026

The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy
07:51

The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy

Published on: June 1, 2019

21.3K
Single-port Non-liposuction Endoscopic Axillary Lymph Node Dissection in Breast Cancer Surgery
11:49

Single-port Non-liposuction Endoscopic Axillary Lymph Node Dissection in Breast Cancer Surgery

Published on: April 3, 2026

481
Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
03:07

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial

Published on: August 19, 2025

1.6K

Area of Science:

  • Oncology
  • Surgical Oncology
  • Breast Cancer Management

Background:

  • Management of regional lymph nodes in local breast cancer recurrence lacks a consensus strategy.
  • Previous axillary surgery can alter lymphatic drainage, complicating lymph node assessment.

Purpose of the Study:

  • To review updated data on the feasibility and accuracy of re-sentinel lymph node biopsy (re-SLNB) in patients with recurrent breast cancer.
  • To evaluate factors influencing re-SLNB success and compare its accuracy to sentinel lymph node biopsy (SLNB) in primary cases.

Main Methods:

  • Systematic review of updated data on re-sentinel lymph node biopsy (re-SLNB) following prior breast cancer surgery.
  • Analysis of identification rates, success factors (previous surgery type, lymph node harvest), and impact of radiotherapy and disease-free interval.
  • Inclusion of data on altered lymphatic drainage and recommendations for imaging techniques (radioisotope method with lymphoscintigraphy).

Main Results:

  • Re-SLNB identification rates ranged from 29% to 100% (mean 67%), influenced by prior surgery and lymph node yield.
  • Re-SLNB demonstrated feasibility even after mastectomy, with no observed impact of post-operative radiotherapy on identification.
  • Altered lymphatic drainage occurred in 32% of cases, highlighting the importance of lymphoscintigraphy; accuracy may rival primary SLNB.

Conclusions:

  • Re-sentinel lymph node biopsy (re-SLNB) is a potentially valuable tool for staging recurrent breast cancer, with accuracy comparable to initial SLNB.
  • The radioisotope method combined with lymphoscintigraphy is recommended due to altered lymphatic drainage.
  • Larger case numbers and longer follow-up are essential for definitive recommendations on re-SLNB in breast cancer recurrence.